Effect of intravenous lignocaine in preventing post operative sorethroat, an intervention study
Not Applicable
Completed
- Conditions
- Health Condition 1: O- Medical and SurgicalHealth Condition 2: O- Medical and Surgical
- Registration Number
- CTRI/2023/06/053564
- Lead Sponsor
- COMMAND HOSPITAL AIRFORCE BANGALORE
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 168
Inclusion Criteria
Patients of either gender, aged between 18 to 65 years, posted for surgeries requiring GA.
-Patients belonged to ASA 1 and 2 will be included
-Patients willing to participate in the study by obtaining the written informed consent
Exclusion Criteria
-Patients with abnormal coagulation profile or on anticoagulation therapy, severe anaemia, hypovolemia, shock, septicaemia and history of seizure disorder.
-Allergy to the study drug.
-Emergency surgeries
-Smoker , prior history of sore throat
-Patients who are on treatment with inhaled steroids for any condition
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method -Analysing the incidence of Post operative sore throat between lignocaine versus normal saline group. <br/ ><br>-Assessing the safety of peri operative intravenous lignocaine in preventing the incidence of sore throat. <br/ ><br>-Incidence of dysphagia and cough between lignocaine versus normal saline group <br/ ><br>Timepoint: specific time at which the outcome will be assessed/estimated i.e.IMMEDIATELY, 6 HR , 12 HR AND 24 HR
- Secondary Outcome Measures
Name Time Method Analysing the efficacy of peri operative intravenous lignocaine in preventing the incidence of sore throatTimepoint: estimated immediately, 6hours , 12 hours and 24 hours